CBU
IBB icon

CIBC Bancorp USA’s iShares Biotechnology ETF IBB Stock Holding History

CIBC Bancorp USA’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
20,331
-10
-0% -$1.72K ﹤0.01% 813
2026
Q1 		$3.43M Buy
+20,341
New +$3.48M ﹤0.01% 803

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

CIBC Bancorp USA's IBB Position: Q2 2026 in Review

CIBC Bancorp USA reduced its iShares Biotechnology ETF (IBB) stake by 0.05% in Q2 2026, selling an estimated $1.72K and leaving 20,331 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #813.

CIBC Bancorp USA first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • CIBC Bancorp USA held 20,331 shares of iShares Biotechnology ETF worth $3.87M as of Q2 2026.
  • CIBC Bancorp USA sold 10 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.72K.
  • iShares Biotechnology ETF made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #813 holding.
  • CIBC Bancorp USA first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.